Key Record Dates
ClinicalTrials.gov Identifier: | NCT04223856 |
---|---|
Brief Title: | Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer (EV-302) |
First Submitted : | January 6, 2020 |
First Submitted that Met QC Criteria : | January 8, 2020 |
First Posted : | January 10, 2020 |
Last Update Submitted that Met QC Criteria : | May 17, 2023 |
Last Update Posted : | May 18, 2023 |